Be4

Bedford, United Kingdom Founded: 2009 • Age: 17 yrs Acquired By UCB
Drug discovery solutions are offered by Beryllium through specialized services.
Request Access

About Be4

Be4 is a company based in Bedford (United Kingdom) founded in 2009 was acquired by UCB in June 2017.. Be4 has raised $11.5 million across 6 funding rounds from investors including UCB and HHS. The company has 55 employees as of December 31, 2018. Be4 has completed 1 acquisition, including Emerald BioSystems. Be4 operates in a competitive market with competitors including Proteros, Syrrx, Nabla, Biomatter and Fina Biosolutions, among others.

  • Headquarter Bedford, United Kingdom
  • Employees 55 as on 31 Dec, 2018
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Beryllium Ltd
  • Date of Incorporation 01 May, 2012
  • Jurisdiction HARROGATE, ENGLAND
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $11.5 M (USD)

    in 6 rounds

  • Latest Funding Round
    $7.5 M (USD), Series A

    Feb 25, 2014

  • Investors
    UCB

    & 1 more

  • Employee Count
    55

    as on Dec 31, 2018

  • Investments & Acquisitions
  • Acquired by
    UCB

    (Jun 06, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Be4

Be4 has successfully raised a total of $11.5M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $7.5 million completed in February 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Series A — $7.5M
  • First Round

    (03 Jul 2008)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2014 Amount Series A - Be4 Valuation UCB
Dec, 2010 Amount Grant - Be4 Valuation

investors

HHS
Nov, 2010 Amount Grant - Be4 Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Be4

Be4 has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include UCB and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Therapies for immunological and neurological disorders are developed.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Be4

Be4 has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Emerald BioSystems. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Laboratory automation, bioinformatics software, reagent kits and plastic-ware products
1998
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Be4

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Be4 Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Be4

Be4 operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Proteros, Syrrx, Nabla, Biomatter and Fina Biosolutions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Drug discovery services are provided to researchers in protein biochemistry.
domain founded_year HQ Location
Provider of drug targets research and clinical trial services
domain founded_year HQ Location
Synthetic biology platform for functional protein identification is provided.
domain founded_year HQ Location
Provider of synthetic biology and AI-based technology for generative protein design
domain founded_year HQ Location
Biotechnology company specializing in bioconjugation services mainly for vaccine development
domain founded_year HQ Location
Protein expression, purification, and structural biology services are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Be4

Frequently Asked Questions about Be4

When was Be4 founded?

Be4 was founded in 2009.

Where is Be4 located?

Be4 is headquartered in Bedford, United Kingdom. It is registered at Bedford, Bedfordshire, United Kingdom.

Is Be4 a funded company?

Be4 is a funded company, having raised a total of $11.5M across 6 funding rounds to date. The company's 1st funding round was a Grant of $99.97K, raised on Jul 03, 2008.

How many employees does Be4 have?

As of Dec 31, 2018, the latest employee count at Be4 is 55.

What does Be4 do?

Beryllium was founded in 2009 and operates from Bedford, United Kingdom, as a contract research organization in the biotechnology sector. Collaborative partnerships are formed with companies to address challenges in drug discovery. Services provided include structure determination using NMR and X-ray crystallography, gene-to-protein production, antibody-antigen characterization, functional biology assays, fragment screening, target gallery development, and membrane protein work.

Who are the top competitors of Be4?

Be4's top competitors include Nabla, Syrrx and Proteros.

How many acquisitions has Be4 made?

Be4 has made 1 acquisition, including Emerald BioSystems.

Who are Be4's investors?

Be4 has 2 investors. Key investors include UCB, and HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available